Skip to main content
. 2021 Mar 17;11:640690. doi: 10.3389/fonc.2021.640690

Table 2.

Progression-Free Survival (PFS) and Overall Survival (OS) for Patients Who Received IO Plus Chemotherapy Compared to Patients Who Received IO Only.

IO + Chemotherapy IO Only p-value2
Median PFS (months)1 5.88
(95% CI, 2.60-10.45)		 2.07
(95% CI, 1.55-2.30)		 <0.001
Median OS
(months)		 18.38
(95% CI, 11.54-28.60)		 9.47
(95% CI, 5.39-13.84)		 0.015

CI, confidence interval

1One observation dropped due to unknown reason going off-study in calculation of PFS.

2p-values generated using log-rank test.